1247 related articles for article (PubMed ID: 25873094)
41. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
42. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
[TBL] [Abstract][Full Text] [Related]
43. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
44. Incidence Changes of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma and Effects on Survival in the Netherlands Cancer Institute, 1980-2009.
Henneman R; Van Monsjou HS; Verhagen CV; Van Velthuysen ML; Ter Haar NT; Osse EM; Lopez-Yurda MI; Balm AJ; Van Den Brekel MW
Anticancer Res; 2015 Jul; 35(7):4015-22. PubMed ID: 26124350
[TBL] [Abstract][Full Text] [Related]
45. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
46. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
47. Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Spector ME; Gallagher KK; Bellile E; Chinn SB; Ibrahim M; Byrd S; Chanowski EJ; Walline HM; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Cordell K; Carey T; Worden FP; Eisbruch A; Chepeha DB
Head Neck; 2014 Sep; 36(9):1233-40. PubMed ID: 23913653
[TBL] [Abstract][Full Text] [Related]
48. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
49. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
[TBL] [Abstract][Full Text] [Related]
51. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
53. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.
Khalid MB; Ting P; Pai A; Russo JL; Bakst R; Chai RL; Teng MS; Genden EM; Miles BA
Laryngoscope; 2019 Apr; 129(4):877-882. PubMed ID: 30194702
[TBL] [Abstract][Full Text] [Related]
54. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
[TBL] [Abstract][Full Text] [Related]
56. Validation of the 8
van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
[TBL] [Abstract][Full Text] [Related]
57. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
58. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
59. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
[TBL] [Abstract][Full Text] [Related]
60. Cause of Death in Patients with Oropharyngeal Carcinoma by Human Papillomavirus Status: Comparative Data Analysis.
Zhang DD; Lei M; Wang Y; Zeng PJ; Hong YJ; Cai CF
JMIR Public Health Surveill; 2023 Aug; 9():e47579. PubMed ID: 37642982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
